BFS
BLUE

Bradley Foster & Sargent’s bluebird bio BLUE Stock Holding History

Bradley Foster & Sargent’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-239
Closed -$283K – 357
2014
Q4 		$283K Buy
+239
New +$160K 0.01% 296

Other funds holding BLUE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Bradley Foster & Sargent's BLUE Position: Q1 2015 in Review

Bradley Foster & Sargent sold out of bluebird bio (BLUE) in Q1 2015, closing a stake of 239 shares — an estimated $283K sold.

Bradley Foster & Sargent first reported a position in BLUE in Q4 2014 and held it in 1 quarter. The position peaked at $283K in Q4 2014. 210 funds tracked by Wall St. Rank hold BLUE as of Q1 2015.

  • Bradley Foster & Sargent reported no remaining bluebird bio position as of Q1 2015 after selling out during the quarter.
  • Bradley Foster & Sargent sold 239 bluebird bio shares in Q1 2015, an estimated $283K.
  • Bradley Foster & Sargent first reported a position in bluebird bio in Q4 2014 and held it in 1 quarter.
  • Bradley Foster & Sargent's bluebird bio position peaked at $283K in Q4 2014.
  • 210 funds tracked by Wall St. Rank held bluebird bio as of Q1 2015.

Based on Bradley Foster & Sargent's 13F filing for Q1 2015, filed 11 May 2015.